# Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT

> **NCT00212017** · NA · TERMINATED · sponsor: **National Cerebral and Cardiovascular Center, Japan** · enrollment: 3000 (actual)

## Conditions studied

- Impaired Glucose Tolerance
- Myocardial Infarction

## Interventions

- **DRUG:** voglibose
- **BEHAVIORAL:** diet and exercise therapy

## Key facts

- **NCT ID:** NCT00212017
- **Lead sponsor:** National Cerebral and Cardiovascular Center, Japan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2012-06
- **Final completion:** 2017-08
- **Target enrollment:** 3000 (ACTUAL)
- **Why stopped:** We obtained the final results due to the interim analysis.
- **Last updated:** 2018-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212017, "Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00212017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*